(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.
Friel, who co-founded Poolbeg Pharma, purchased the shares at an average price of 11.68p each, for a total value of £96,944.

Following the transaction, Friel holds 37.21m ordinary...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE